Nature Reviews Drug Discovery Impact Factor, Indexing, Ranking

Nature Reviews Drug Discovery (NRDD) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics. Nature Publishing is the publisher of this esteemed journal. The P-ISSN assigned to Nature Reviews Drug Discovery is 1474-1776 and its abbreviated form is Nat Rev Drug Discov.

Aims & Scope

Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.

Subjects covered

• Target discovery and validation
• High-throughput screening
• Novel therapeutic strategies 
• Rational drug design
• Medicinal chemistry
• Natural products
• Informatics
• Pharmacology
• Toxicology
• 'Omic' technologies
• Drug delivery
• Biopharmaceuticals
• Biotechnology
• Vaccines
• Clinical trials
• Drug regulation
• Market analysis
• Strategic issues
• Industry trends
• Intellectual property
• Pharmacoeconomics

Nature Reviews Drug Discovery Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Nature Reviews Drug Discovery Journal is Nat Rev Drug Discov.

The Ranking of Nature Reviews Drug Discovery in 2026 is 17. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Impact Factor of Nature Reviews Drug Discovery in 2026 is 112.288. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The SCImago of Nature Reviews Drug Discovery in 2026 is 19.423. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The H-Index of Nature Reviews Drug Discovery in 2026 is 370. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Nature Reviews Drug Discovery is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. PubMed
• 5. Medline

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of Nature Reviews Drug Discovery is Peter Kirkpatrick, PhD

Nature Reviews Drug Discovery Call for paper : Nature Reviews Drug Discovery invites original research contributions for consideration of publication in Nature Reviews Drug Discovery journal.

Journal seeking submissions in the broad areas of Pharmacology, Toxicology and Pharmaceutics that align with journal's focus on Pharmacology, Toxicology and Pharmaceutics.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Nature Reviews Drug Discovery involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Pharmacology, Toxicology and Pharmaceutics.
• Familiarize Yourself: Read and understand the aims and scope of Nature Reviews Drug Discovery to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Nature Reviews Drug Discovery guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago